Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 24.67% is in line with its 5-year average of 23.85%, around the middle of its 5-year range (21.42%–26.64%).
1.42% below its 12-month average of 25.02%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
24.67%
RETURN ON ASSETS (ROA) AVG TTM
25.02%
RETURN ON ASSETS (ROA) AVG 3Y
24.63%
RETURN ON ASSETS (ROA) AVG 5Y
23.85%
RETURN ON ASSETS (ROA) AVG 10Y
21.21%
RETURN ON ASSETS (ROA) AVG 15Y
18.82%
RETURN ON ASSETS (ROA) AVG 20Y
16.69%
CURRENT VS TTM AVG
-1.42%
CURRENT VS 3Y AVG
+0.14%
CURRENT VS 5Y AVG
+3.46%
CURRENT VS 10Y AVG
+16.34%
CURRENT VS 15Y AVG
+31.09%
CURRENT VS 20Y AVG
+47.84%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+379.96%
vs the sector median at left
Mettler-Toledo International Inc.
Market Cap
$26.79B
Return on Assets (ROA)
24.67%
TTM Avg
25.02%
3Y Avg
24.63%
5Y Avg
23.85%
Market Cap
$26.64B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
Market Cap
$25.99B
Return on Assets (ROA)
6.27%
TTM Avg
5.75%
3Y Avg
6.24%
5Y Avg
8.30%
Market Cap
$25.22B
Return on Assets (ROA)
20.48%
TTM Avg
9.54%
3Y Avg
8.43%
5Y Avg
7.44%
Market Cap
$24.78B
Return on Assets (ROA)
-8.40%
TTM Avg
-3.96%
3Y Avg
9.16%
5Y Avg
17.06%
Market Cap
$29.33B
Return on Assets (ROA)
1.76%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
Market Cap
$23.79B
Return on Assets (ROA)
13.86%
TTM Avg
12.54%
3Y Avg
14.20%
5Y Avg
14.86%
Market Cap
$30.13B
Return on Assets (ROA)
0.67%
TTM Avg
13.34%
3Y Avg
15.53%
5Y Avg
17.15%
Market Cap
$30.16B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.79B | 24.67% | 25.02% | 24.63% | 23.85% |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 5.41% | 4.41% | 4.42% | 6.18% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.99B | 6.27% | 5.75% | 6.24% | 8.30% |
| Incyte Corporation (INCY)vs › | $25.22B | 20.48% | 9.54% | 8.43% | 7.44% |
| BioNTech SE (BNTX)vs › | $24.78B | -8.40% | -3.96% | 9.16% | 17.06% |
| Medline Inc. (MDLN)vs › | $29.33B | 1.76% | 3.17% | 1.75% | 1.75% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.79B | 13.86% | 12.54% | 14.20% | 14.86% |
| Waters Corporation (WAT)vs › | $30.13B | 0.67% | 13.34% | 15.53% | 17.15% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 4.27% | 5.83% | 5.87% | 14.86% |
| Zoetis Inc. (ZTS)vs › | $30.86B | 17.35% | 17.37% | 16.33% | 15.33% |
ROA
24.7%
ROE
7062.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 23.41% |
| 2024-12-31 | 26.64% |
| 2023-12-31 | 23.51% |
| 2022-12-31 | 24.98% |
| 2021-12-31 | 23.11% |
| 2020-12-31 | 21.42% |
| 2019-12-31 | 20.12% |
| 2018-12-31 | 19.57% |
| 2017-12-31 | 14.75% |
| 2016-12-31 | 17.74% |
| 2015-12-31 | 18.01% |
| 2014-12-31 | 16.84% |
| 2013-12-31 | 14.22% |
| 2012-12-31 | 14.38% |
| 2011-12-31 | 12.23% |
| 2010-12-31 | 10.17% |
| 2009-12-31 | 10.04% |
| 2008-12-31 | 12.19% |
| 2007-12-31 | 10.64% |
| 2006-12-31 | 9.93% |
| 2005-12-31 | 6.52% |
| 2004-12-31 | 7.29% |
| 2003-12-31 | 6.91% |
| 2002-12-31 | 7.70% |
| 2001-12-31 | 6.08% |
| 2000-12-31 | 7.90% |
| 1999-12-31 | 5.86% |
| 1998-12-31 | 4.58% |
| 1997-12-31 | -8.79% |
